Delivery Order SPE2DB20D7059-SPE2DB23FQEQ7
Award Date 7/11/23
Potential Completion Date 7/12/23
Potential Value $682
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $794.04 delivery order contract to Amerisourcebergen Drug Corporation for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The firm fixed price contract has a period of performance from July 25, 2023 through July 26, 2023. Amerisourcebergen Drug Corporation, operating from its Conshohocken, Pennsylvania location, will deliver the pediatric hepatitis B vaccine to the Defense Logistics Agency. No major subcontractors or set aside designations were indicated. The brief...
- The Defense Logistics Agency awarded a $1,255.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for the delivery of pediatric hepatitis B vaccine and has a period of performance from July 10-11, 2023. As the DLA supports all Department of Defense branches, this order is likely associated with the agency's medical supply chain...
- The Defense Logistics Agency awarded a $147,000 delivery order contract to Amerisourcebergen Drug Corporation for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The contract has a period of performance from July 11, 2023 through July 12, 2023 and utilizes a firm fixed price payment structure. Amerisourcebergen will deliver the pediatric hepatitis B vaccine to a location in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply procurement programs. No subcontractors or set...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,447.26 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRINGE 0.5ML, a pediatric hepatitis B vaccine product. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, was competitively awarded with no set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $661.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from August 18, 2023 through August 21, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United States Department of Defense, this delivery order is...
- The Defense Logistics Agency awarded a $3,701 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The order is to be performed by Amerisourcebergen's Conshohocken, Pennsylvania facility under the parent company Amerisourcebergen Corporation's corporate office division contract vehicle. No set aside designation or subcontractors are indicated. The Defense Logistics Agency supports military readiness by procuring, managing and...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $38,113.92 to Amerisourcebergen Drug Corporation for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order period of performance is July 31, 2023 through August 1, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United States Department of Defense, this delivery...
- The Defense Logistics Agency awarded a $7,410.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ENGERIX-B 20 MCG/ML SYRNML. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pediatric hepatitis B vaccines. Amerisourcebergen will deliver the vaccines from its facility in Conshohocken, Pennsylvania by September 14, 2023 to support the Department of Defense's immunization programs. No subcontractors or set-aside...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,505 to Amerisourcebergen Drug Corporation for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on July 31, 2023 and ending on August 1, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United States Department...
- The Defense Logistics Agency awarded a $586 delivery order to Amerisourcebergen Drug Corporation for ENGERIX-B 20 MCG/ML SYRNML. The firm fixed price order is being fulfilled under the Prime Vendor Program prime vendor contract vehicle. Amerisourcebergen will deliver the pediatric hepatitis B vaccine to its Conshohocken, Pennsylvania distribution center from July 31 to August 1, 2023 to support the Department of Defense's immunization stockpile needs. No set aside designation or subcontractors...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB23FQEQ7Delivery Order
The Defense Logistics Agency awarded a $681.74 delivery order contract to Amerisourcebergen Drug Corporation for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The firm fixed price contract has a period of performance from July 11, 2023 through July 12, 2023. Amerisourcebergen will deliver the pediatric hepatitis B vaccine to its Conshohocken, Pennsylvania location in support of the Defense Logistics Agency's medical supply chain responsibilities. No major subcontractors or set aside designations were indicated. The brief duration and item description suggest this delivery order was placed under the DLA's pharmaceutical prime vendor contract vehicle to meet immediate immunization needs.
Generated 12/23/23, 4:51 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $682 | 7/11/23 |